121
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Resveratrol protects against ox-LDL-induced endothelial dysfunction in atherosclerosis via depending on circ_0091822/miR-106b-5p-mediated upregulation of TLR4

, , &
Pages 915-924 | Received 01 Jan 2022, Accepted 17 Jun 2022, Published online: 11 Jul 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Siti Sarah Azman, Muhammad Dain Yazid, Nur Azurah Abdul Ghani, Raja Zahratul Azma Raja Sabudin, Mohd Ramzisham Abdul Rahman & Nadiah Sulaiman. (2023) Generation of a novel ex-vivo model to study re-endothelialization. Artificial Cells, Nanomedicine, and Biotechnology 51:1, pages 408-416.
Read now

Articles from other publishers (3)

Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Rosario Mireya Romero-Parra, Ghadeer Sabah Bustani, Ahmed Hjazi, Mohammed.I. Alghamdi, Ali Kamil Kareem, Enas R. Alwaily, Rahman S. Zabibah, Jitendra Gupta, Reza Mahmoudi & Seyedreza Hosseini-Fard. (2023) NLRP3 inflammasome pathway in atherosclerosis: Focusing on the therapeutic potential of non-coding RNAs. Pathology - Research and Practice 246, pages 154490.
Crossref
Krishna Veerubhotla, Hillary McGraw & Chi H Lee. (2023) Assessment of Biocompatibility of 3D‐Printed Cardiovascular Stent. Advanced Therapeutics 6:5.
Crossref
Tianwei Meng, Xinghua Li, Chengjia Li, Jiawen Liu, Hong Chang, Nan Jiang, Jiarui Li, Yabin Zhou & Zhiping Liu. (2022) Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways. Frontiers in Pharmacology 13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.